January 4, 2012 1:33 pm by Stephanie Baum | 0 Comments
Ossianix, an early stage biopharmaceutical startup that utilizes shark antibodies as a model for drugs to treat central nervous system disorders, has received a strategic investment from Danish pharmaceutical company ...
Read more